Proposed | ||||||
---|---|---|---|---|---|---|
Pathway name | Entities | Reactions | ||||
found | ratio | p-value | FDR* | found | ratio | |
Nuclear signaling by ERBB4 | 3 / 35 | 0.002 | 5.37e-05 | 0.012 | 3 / 22 | 0.002 |
Signaling by interleukins | 7 / 640 | 0.046 | 2.60e-04 | 0.019 | 6 / 491 | 0.041 |
MECP2 regulates transcription of neuronal ligands | 3 / 61 | 0.004 | 2.74e-04 | 0.019 | 3 / 37 | 0.003 |
Signaling by receptor tyrosine kinases | 2 / 13 | 9.25e-04 | 3.41e-04 | 0.019 | 2 / 8 | 6.68e-04 |
NRIF signals cell death from the nucleus | 6 / 521 | 0.037 | 5.89e-04 | 0.023 | 71 / 633 | 0.053 |
Co-occurrence | ||||||
MECP2 regulates transcription of neuronal ligands | 2 / 13 | 9.25e-04 | 3.18e-04 | 0.036 | 2 / 8 | 6.68e-04 |
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | 2 / 17 | 0.001 | 5.41e-04 | 0.036 | 2 / 20 | 0.002 |
NRIF signals cell death from the nucleus | 2 / 18 | 0.001 | 6.06e-04 | 0.036 | 4 / 7 | 5.84e-04 |
Amyloid fiber formation | 3 / 88 | 0.006 | 7.15e-04 | 0.036 | 16 / 33 | 0.003 |
Neurodegenerative diseases | 2 / 30 | 0.002 | 0.002 | 0.056 | 2 / 22 | 0.002 |
COALS | ||||||
Plasma lipoprotein assembly | 3 / 30 | 0.002 | 4.18e-05 | 0.01 | 8 / 19 | 0.002 |
MECP2 regulates transcription of neuronal ligands | 2 / 13 | 9.25e-04 | 3.91e-04 | 0.042 | 2 / 8 | 6.68e-04 |
HDL assembly | 2 / 18 | 0.001 | 7.44e-04 | 0.042 | 7 / 9 | 7.51e-04 |
NRIF signals cell death from the nucleus | 2 / 18 | 0.001 | 7.44e-04 | 0.042 | 4 / 7 | 5.84e-04 |
Amyloid fiber formation | 3 / 88 | 0.006 | 9.67e-04 | 0.044 | 16 / 33 | 0.003 |
Word2Vec | ||||||
Transfer of LPS from LBP carrier to CD14 | 1 / 3 | 2.13e-04 | 0.005 | 0.075 | 2 / 2 | 1.67e-04 |
NTF3 activates NTRK2 (TRKB) signaling | 1 / 4 | 2.85e-04 | 0.006 | 0.075 | 3 / 3 | 2.50e-04 |
NTF4 activates NTRK2 (TRKB) signaling | 1 / 4 | 2.85e-04 | 0.006 | 0.075 | 3 / 3 | 2.50e-04 |
BDNF activates NTRK2 (TRKB) signaling | 1 / 4 | 2.85e-04 | 0.006 | 0.075 | 3 / 3 | 2.50e-04 |
Defective GSS causes glutathione synthetase deficiency (GSS deficiency) | 1 / 4 | 2.85e-04 | 0.006 | 0.075 | 1 / 1 | 8.34e-05 |